BIOTECHNOLOGY looks at news relating to biotech companies, their financial performance, licensing, research, and merger & acquisition activities. At this time of new legislation and activities in the area of “biosimilars: or “biogenerics” approvals, which have progressed more in Europe and are likely to impact the huge US market quite soon, watching this area will be an important aspect for subscribers and those active in the sector.